Identification of SRC, AKT1 and MAPK3 as therapeutic targets of apigenin and luteolin in colorectal and colon carcinoma through network pharmacology
Authors:
Open Access
- 6 March 2025
- journal article
- Published by Elsevier in Food Bioscience
- Vol. 67
Abstract
No abstract availableFunding Information
- Monash University Malaysia
This publication has 94 references indexed in Scilit:
- A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanismsFood Science & Nutrition, 2023
- The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticlesJournal of Cellular Physiology, 2021
- KEGG mapping tools for uncovering hidden features in biological dataProtein Science, 2021
- Toward understanding the origin and evolution of cellular organismsProtein Science, 2019
- RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical educationProtein Science, 2017
- Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and ProgressJournal of Cellular Biochemistry, 2017
- Green tea polyphenol EGCG suppresses Wnt/β‐catenin signaling by promoting GSK‐3β‐ and PP2A‐independent β‐catenin phosphorylation/degradationBioFactors, 2014
- The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cellsClinical & Experimental Metastasis, 2011
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- Automated docking of substrates to proteins by simulated annealingProteins: Structure, Function, and Bioinformatics, 1990